| Entry |
|
|---|
| Name |
Sulindac (JP18/USP/INN);
Clinoril (TN) |
|---|
| Product |
|
|---|
| Generic |
SULINDAC (A-S Medication Solutions), SULINDAC (Actavis Pharma), SULINDAC (Bryant Ranch Prepack), SULINDAC (Bryant Ranch Prepack), SULINDAC (Epic Pharma), SULINDAC (Lake Erie Medical DBA Quality Care Products LLC), SULINDAC (Major Pharmaceuticals), SULINDAC (Major Pharmaceuticals), SULINDAC (PD-Rx Pharmaceuticals), SULINDAC (Proficient Rx LP), SULINDAC (PuraCap Laboratories LLC dba Blu Pharmaceuticals), SULINDAC (Sun Pharmaceutical Industries) |
|---|
| Formula |
C20H17FO3S
|
|---|
| Exact mass |
356.0882
|
|---|
| Mol weight |
356.4106
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01906 Anti-inflammatory drug, acetic acid derivatives
|
|---|
| Remark |
| Therapeutic category: | 1149 |
|
|---|
| Efficacy |
Analgesic, Anti-inflammatory, COX inhibitor |
|---|
| Comment |
Acetic acid derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01AB Acetic acid derivatives and related substances
M01AB02 Sulindac
D00120 Sulindac (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Analgesics
Nonsteroidal Anti-inflammatory Drugs
Sulindac
D00120 Sulindac (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
114 Antipyretics and analgesics, anti-inflammatory agents
1149 Others
D00120 Sulindac (JP18/USP/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01906 Anti-inflammatory drug, acetic acid derivatives
D00120 Sulindac
Drug classes [BR:br08332]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
D00120 Sulindac
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS1 (COX1)
D00120 Sulindac (JP18/USP/INN) <JP/US>
PTGS2 (COX2)
D00120 Sulindac (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00120 Sulindac
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 25
1 C8y C 21.4726 -14.1927
2 C8y C 21.4726 -12.8437
3 C2y C 22.6354 -14.8905
4 C8x C 20.2632 -14.8905
5 C2y C 23.8449 -12.8437
6 C8x C 20.2632 -12.1460
7 C2y C 23.8449 -14.1927
8 C2b C 22.6354 -16.2394
9 C8x C 19.1003 -14.1927
10 C8y C 19.1003 -12.8437
11 C1a C 24.9378 -14.9605
12 C8y C 21.4726 -16.9371
13 X F 17.9374 -12.1460
14 C8x C 21.4726 -18.2860
15 C8x C 20.3097 -16.2394
16 C8x C 20.3097 -18.9373
17 C8x C 19.1468 -16.9371
18 C8y C 19.1468 -18.2860
19 S4a S 17.9840 -18.9373
20 C1a C 16.8210 -18.2395
21 O3c O 17.9840 -20.4962
22 C1b C 25.0421 -12.1357
23 C6a C 26.2621 -12.8232
24 O6a O 27.4570 -12.1165
25 O6a O 26.2769 -14.2361
BOND 27
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 2
9 6 10 2
10 7 11 1
11 8 12 1
12 10 13 1
13 12 14 2
14 12 15 1
15 14 16 1
16 15 17 2
17 16 18 2
18 18 19 1
19 19 20 1
20 19 21 2
21 5 7 2
22 9 10 1
23 17 18 1
24 5 22 1
25 22 23 1
26 23 24 1
27 23 25 2
|
|---|
